Edition 52 – An Open Letter to American Academic Institutions: Stand Behind the Evidence

An Open Letter to American Academic Institutions: Stand Behind the Evidence

An Open Letter to American Academic Institutions: Stand Behind the Evidence By Neil Singh Bedi, Rachel J. Smith, Marina L. Weiss Citation Bedi N, Smith R, Weiss M. An open letter to American academic institutions: stand behind the evidence. HPHR. 2023;52. https://doi.org/10.54111/0001/ZZ5 An Open Letter to American Academic Institutions: Stand Behind the Evidence Abstract In […]

Edition 54 – Underinsurance among Privately Insured US Children: Findings from the National Survey of Children’s Health 2020

Edition 54 – Underinsurance among Privately Insured US Children: Findings from the National Survey of Children’s Health 2020

Underinsurance among Privately Insured US Children: Findings from the National Survey of Children’s Health 2020 Menolly Kaufman PhD, MPH; Shauna Petchel PhD, MPH Facebook Twitter LinkedIn Citation Kaufman M, Petchel S. Underinsurance among privately insured US children: findings from the national survey of children’s health 2020. HPHR. 2023.54. 10.54111/0001/BBB8 Underinsurance among Privately Insured US Children: […]

Edition 74 – Denouncing Medical Practices that Imperil Unaccompanied Youth

Denouncing Medical Practices that Imperil Unaccompanied Youth​

Denouncing Medical Practices That Imperil Unaccompanied Youth By Lauren Heidbrink, PhD, Sarah Diaz, JD, LLM, Facebook Twitter LinkedIn Citation Heidbrink H, Diaz S. Denouncing medical practices that imperil unaccompanied youth. HPHR. 2023;74. https://doi.org/10.54111/0001/VVV1 Denouncing Medical Practices that Imperil Unaccompanied Youth Abstract Unaccompanied children detained in the US are subject to questionable medical practices to verify […]

Edition 60- Lessons from COVID-19 – Building a more resilient response for the next pandemic – Health System and Drug Development perspectives

Edition 60- Lessons from COVID-19 - Building a more resilient response for the next pandemic - Health System and Drug Development perspectives

Lessons from COVID-19: Building a More Resilient Response for the Next Pandemic – Health System and Drug Development Perspectives By Preet Kukreja, Kinshuk Saxena, Snigdha Santra Facebook Twitter LinkedIn Citation Kukreja P, Saxena K, Santra S. Lessons from COVID-19 – building a more resilient response for the next pandemic – health system and drug development […]

Edition 71 – The global economic burden of youth self-harm: A systematic analysis of 204 countries and territories for 2019

Edition 71 - The global economic burden of youth self-harm: A systematic analysis of 204 countries and territories for 2019

Globally, young people (<24 years of age) contribute to about a quarter of the total disease burden of self-harm. However, national strategic plans have been found to have no specific recommendations for managing children and young people suffering from suicidality or preventing youth self-harm. Limited policy attention and allocation of funds can be partially attributed to limited evidence on the economic burden of self-harm. Beyond ethical and health arguments, a high economic burden could persuade policy action. Hence, understanding the global economic burden of youth self-harm including that in low- and middle-income countries (LMICs) is crucial.

Edition 73 – COVID-19 and Malaria Vaccine Advanced Market Commitments: Opportunities to Incentivize Investment in Africa’s Vaccine Manufacturing Industry

: COVID-19 and Malaria Vaccine Advanced Market Commitments: Opportunities to Incentivize Investment in Africa’s Vaccine Manufacturing Industry

This literature review instills a comprehensive understanding of the costs associated with vaccine manufacturing development in the Africa region and draws particular focus to the prices paid by African national governments for the recently rolled out COVID-19 vaccines through the COMAX AMC as well as the estimated costs (based on birth cohort data and DPT vaccination coverage data) of the recently WHO recommended malaria vaccine program.

Edition 57 – Local Ecological Knowledge: A New Evidence Base for Health Research

Edition 57 – Local Ecological Knowledge: A New Evidence Base for Health Research

Local Ecological Knowledge: A New Evidence Base for Health Research By Lisa Shanti Chaudhari, Xotchitl M. Flores-Marcial, Natale Zappia Svetlana Tyutina, Judith C. P. Lin, Danette Archer, Jonatan Garcia Martinez, Araceli Garcia Antonio, Jonathan Garzon, Julio Cesar Lopez-Flores, Carrie L. Saetermoe Facebook Twitter LinkedIn Citation Chaudhari L. Flores-Marcial X, Zappia N, Tyutina S, Lin J, […]

Scaling up Health Services for Type 1 Diabetes in India, 2023

Scaling up Health Services for Type 1 Diabetes in India, 2023

This report, “Scaling up Health Services for Type 1 Diabetes in India: Towards a strategy to transition to sustainability of programmes supported by CDIC in India ”, was developed under the guidance of Professor Rifat Atun, Professor of Global Health Systems at Harvard University and Director of the Health Systems Innovation Lab. The study was supported by Novo Nordisk financially supported this work through a research grant. The funders had no role in study design, analysis, decision to publish, or report preparation.